Advanced science (Weinheim, Baden-Wurttemberg, Germany)
April 1, 2026
Jiawei Zhu, Xiaoyu Bao, Qiyun Huang et al.
Car sickness, an enormous vehicular travel challenge, affects a significant proportion of the population. Pharmacological interventions are limited by adverse side effects, and effective nonpharmacological alternatives remain to be identified. Here, we introduce a novel attention-shifting method based on a closed-loop, artificial intelligence (AI)-driven, wearable mindfulness brain-computer...
BMC Anesthesiology
July 5, 2025
Dujuan Qiao, Wei Liu, Huanjia Xue et al.
5 citations
Esketamine exerts analgesic effects and has pharmacological properties of bronchodilation and elevation of mean arterial pressure, making it an interesting analgesic agent for patients with ARDS. Therefore, we conducted a randomized controlled trial comparing the effects of esketamine/midazolam and remifentanil/midazolam on respiratory mechanics and oxygenation in mechanically ventilated...
BMC Palliative Care
September 28, 2024
Catherine E Mosher, Kathleen A Beck-Coon, Wei Wu et al.
17 citations
Patients with advanced cancer and family caregivers often use avoidant coping strategies, such as delaying advance care planning discussions, which contribute to deterioration in their quality of life. Mindfulness-based interventions have shown promise in improving quality of life in this population but have rarely been applied to advance care planning. This pilot trial examined the preliminary...
Psycho-oncology
2024
Stella Snyder, Ekin Secinti, Kelly Chinh et al.
6 citations
A brief, valid, and comprehensive measure of mindfulness is needed for cancer populations. This study examined the factor structure, internal consistency, construct validity, and measurement invariance of the 10-item Cognitive Affective Mindfulness Scale-Revised (CAMS-R) in patients with cancer. Patients with breast, gastrointestinal, lung, or prostate cancer (N = 404, 50% stage IV cancer, 51%...